Trials / Completed
CompletedNCT00132886
Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure
Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Single Oral Tolvaptan Tablets on Hemodynamic Parameters in Subjects With Heart Failure
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will look at how a single dose of study medication (tolvaptan) versus an inactive sugar pill (placebo) effect pressures in the heart in patients with congestive heart failure. Higher than normal pressures can be related to symptoms of heart failure (shortness of breath, fatigue, etc.).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tolvaptan |
Timeline
- Start date
- 2004-12-01
- Primary completion
- 2006-12-01
- Completion
- 2006-12-01
- First posted
- 2005-08-22
- Last updated
- 2012-05-03
Locations
31 sites across 2 countries: United States, Romania
Source: ClinicalTrials.gov record NCT00132886. Inclusion in this directory is not an endorsement.